OFAC Sanctions Chinese Companies, Officials for Trafficking Opioids
The Office of Foreign Assets Control this week sanctioned China-based Guangzhou Tengyue Chemical Co., which it said is involved in the manufacture and sale of synthetic opioids to Americans. The agency also sanctioned Huang Xiaojun and Huang Zhanpeng, two representatives of Guangzhou Tengyue who were "directly involved in coordinating the shipments" of those illegal drugs and dangerous chemicals to the U.S.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
DOJ last year indicted Guangzhou Tengyue and Xiaojun on charges related to synthetic opioid distribution, but OFAC said "the company continued to operate." It said the company has coordinated sales of medetomidine -- a chemical used as a cutting agent that is mixed with synthetic opioids -- to customers in the U.S. as recently as this year.